← Back to Search

Exercise Program for Breast Cancer

N/A
Recruiting
Led By Jami Fukui, MD
Research Sponsored by University of Hawaii
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant must be able to lie flat on their back for up to 10 minutes
Participant must be able to stand without aid for at least 2 minutes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial is testing if an exercise program can change the body composition of breast cancer patients, and if they can keep up the physical activity after the program.

Who is the study for?
This trial is for individuals newly diagnosed with breast cancer (within the past 2 years, stages I-III) who can be undergoing various treatments. Participants must be able to perform physical activities like lying flat and standing without aid, and commit to a 12-week exercise program including assessments.Check my eligibility
What is being tested?
The study tests the impact of a 12-week exercise regimen on body composition in breast cancer patients. It also aims to identify factors that encourage ongoing physical activity post-intervention.See study design
What are the potential side effects?
While not explicitly listed, potential side effects from participating in an exercise program may include muscle soreness, fatigue, and risk of injury. Specific side effects will depend on individual health status.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can lie flat on my back for up to 10 minutes.
Select...
I can stand on my own for at least 2 minutes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Automatic 3D optical (3DO) scan measurement: girth measurement
Automatic 3D optical (3DO) scan measurement: length measurement
Automatic 3D optical (3DO) scan measurement: volume measurement
+8 more
Secondary outcome measures
BFI-Brief Fatigue Innovatory questionnaire
BIBCQ-Body Image After Breast Cancer questionnaire
Biomarkers
+4 more

Trial Design

2Treatment groups
Active Control
Group I: Group 2 - Declines Exercise ProgramActive Control1 Intervention
Same biometric and biomarker assessment at as Group 1 (at baseline, after 12 weeks and annually) however they will not participate in the exercise sessions
Group II: Group 1 - Agree to Exercise ProgramActive Control1 Intervention
12-week exercise program

Find a Location

Who is running the clinical trial?

Rehabilitation Hospital of the PacificUNKNOWN
University of HawaiiLead Sponsor
115 Previous Clinical Trials
54,524 Total Patients Enrolled
2 Trials studying Breast Cancer
673 Patients Enrolled for Breast Cancer
Jami Fukui, MDPrincipal InvestigatorUniversity of Hawaii Cancer Research Center

Media Library

Group 1 - Agree to Exercise Program Clinical Trial Eligibility Overview. Trial Name: NCT04013568 — N/A
Breast Cancer Research Study Groups: Group 2 - Declines Exercise Program, Group 1 - Agree to Exercise Program
Breast Cancer Clinical Trial 2023: Group 1 - Agree to Exercise Program Highlights & Side Effects. Trial Name: NCT04013568 — N/A
Group 1 - Agree to Exercise Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04013568 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What outcomes is this exploration aiming to prove?

"This medical trial's primary focus is to evaluate Automatic 3D optical (3DO) scan measurements of length. Additionally, researchers are employing the Diet History Questionnaire II as a measure of self-reported energy intake and kcal/day, the BIBCQ-Body Image After Breast cancer questionnaire with 45 items, and BFI-Brief Fatigue Innovatory questionnaire with 9 components over roughly one day."

Answered by AI

To what extent is enrollment available for this clinical trial?

"Affirmative. According to the information found on clinicaltrials.gov, this medical research is currently open for enrolment; it was initially posted on August 28th 2019 and last updated October 14th 2022. The goal is to recruit 165 individuals from 1 location."

Answered by AI

Are there still open slots for participants in this investigation?

"That is accurate. As per the information hosted on clinicaltrials.gov, this medical study initially went live on August 28th 2019 and was recently edited October 14th 2022. 165 individuals need to be recruited from 1 centre for participation in the trial."

Answered by AI
~55 spots leftby Sep 2026